{"id":39975,"date":"2017-07-26T07:17:17","date_gmt":"2017-07-26T11:17:17","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=39975"},"modified":"2017-07-26T05:18:08","modified_gmt":"2017-07-26T09:18:08","slug":"amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975","title":{"rendered":"Amgen, Inc. (NASDAQ:AMGN) And Array Biopharma Inc (NASDAQ:ARRY) Partners For Inflammation Discoveries"},"content":{"rendered":"<p><strong>Amgen, Inc. (NASDAQ:AMGN)<\/strong> and Array Biopharma Inc (NASDAQ:ARRAY) have announced today the partnership agreement as an effort to discover and develop new drugs for autoimmune diseases. The unrevealed target and lead inhibitors were found out through the Array\u2019s proprietary podium that leverages its capability in chemistry and early development.<\/p>\n<p>Array Biopharma made a deal with the industry giant to manufacture drugs for the autoimmune disorders that have become complex in the recent past years. The collaboration will enable the two companies to advance the studies on molecules into their clinics so as to provide new treatment alternatives for patients.<\/p>\n<p>Amgen is a leading company in the treatment of inflammatory diseases and the new deal could help Array develop an effective drug that will significantly address the existing gaps in the medical field. The agreement terms state that the two companies will join forces in preclinical development as Array leads the chemistry medicinal work.<\/p>\n<p>Also, Amgen will carry out both the clinical development and commercialization. Amgen will, therefore, make both upfront and milestone payments as well as the royalties payments. According to the chief scientific officer at Array Nicholas Saccomano, the new target together with their capable team in kinase inhibitor chemistry will enable them to obtain a drug that will relieve patients suffering from the inflammatory disease.<\/p>\n<p>The partnership will help the two firms to team up their resources to develop the much-awaited drug. In May, Array partnered with another pharmaceutical giant known as Bristol-Myres Squibb to carry out clinical tests to the efficiency of Array\u2019s binimetinib drug by combining it with Bristol-Myers\u2019 drug in order to treat colorectal cancer.<\/p>\n<p>It\u2019s hoped that the findings will be a major milestone in managing the inflammation disorders. With more than 20 years of experience in the pharmaceutical industry, Amgen brings its knowledge, skills, and expertise needed to help in discovering the right drug for the autoimmune illnesses. The new agreement builds on Amgen\u2019s continued focus in the inflammation, which is one of the company\u2019s critical areas of interest.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Amgen, Inc. (NASDAQ:AMGN) and Array Biopharma Inc (NASDAQ:ARRAY) have announced today the partnership agreement as an effort to discover and develop new drugs for autoimmune [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":39982,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[7095,2831,128,12612,12794,358,1520,12795],"stock_ticker":[],"class_list":["post-39975","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-amgen-inc","tag-amgen-inc-nasdaqamgn","tag-amgn","tag-array-biopharma-inc","tag-array-biopharma-inc-nasdaqarray","tag-nasdaq","tag-nasdaqamgn","tag-nasdaqarray","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Amgen, Inc. (NASDAQ:AMGN) And Array Biopharma Inc (NASDAQ:ARRY) Partners For Inflammation Discoveries - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Amgen, Inc. (NASDAQ:AMGN) And Array Biopharma Inc (NASDAQ:ARRY) Partners For Inflammation Discoveries - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Amgen, Inc. (NASDAQ:AMGN) and Array Biopharma Inc (NASDAQ:ARRAY) have announced today the partnership agreement as an effort to discover and develop new drugs for autoimmune [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-07-26T11:17:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/07\/39981-images__7_.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"275\" \/>\n\t<meta property=\"og:image:height\" content=\"183\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Benjamin Roussey\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benjamin Roussey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975\"},\"author\":{\"name\":\"Benjamin Roussey\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\"},\"headline\":\"Amgen, Inc. (NASDAQ:AMGN) And Array Biopharma Inc (NASDAQ:ARRY) Partners For Inflammation Discoveries\",\"datePublished\":\"2017-07-26T11:17:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975\"},\"wordCount\":356,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/07\/39981-images__7_.jpeg\",\"keywords\":[\"Amgen Inc.\",\"Amgen Inc. (NASDAQ:AMGN)\",\"AMGN\",\"Array Biopharma Inc\",\"Array Biopharma Inc (NASDAQ:ARRAY)\",\"NASDAQ\",\"NASDAQ:AMGN\",\"NASDAQ:ARRAY\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975\",\"name\":\"Amgen, Inc. (NASDAQ:AMGN) And Array Biopharma Inc (NASDAQ:ARRY) Partners For Inflammation Discoveries - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/07\/39981-images__7_.jpeg\",\"datePublished\":\"2017-07-26T11:17:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/07\/39981-images__7_.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/07\/39981-images__7_.jpeg\",\"width\":275,\"height\":183},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Amgen, Inc. (NASDAQ:AMGN) And Array Biopharma Inc (NASDAQ:ARRY) Partners For Inflammation Discoveries\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d\",\"name\":\"Benjamin Roussey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g\",\"caption\":\"Benjamin Roussey\"},\"description\":\"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Amgen, Inc. (NASDAQ:AMGN) And Array Biopharma Inc (NASDAQ:ARRY) Partners For Inflammation Discoveries - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975","og_locale":"en_US","og_type":"article","og_title":"Amgen, Inc. (NASDAQ:AMGN) And Array Biopharma Inc (NASDAQ:ARRY) Partners For Inflammation Discoveries - Wall Street PR","og_description":"Amgen, Inc. (NASDAQ:AMGN) and Array Biopharma Inc (NASDAQ:ARRAY) have announced today the partnership agreement as an effort to discover and develop new drugs for autoimmune [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2017-07-26T11:17:17+00:00","og_image":[{"width":275,"height":183,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/07\/39981-images__7_.jpeg","type":"image\/jpeg"}],"author":"Benjamin Roussey","twitter_misc":{"Written by":"Benjamin Roussey","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975"},"author":{"name":"Benjamin Roussey","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d"},"headline":"Amgen, Inc. (NASDAQ:AMGN) And Array Biopharma Inc (NASDAQ:ARRY) Partners For Inflammation Discoveries","datePublished":"2017-07-26T11:17:17+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975"},"wordCount":356,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/07\/39981-images__7_.jpeg","keywords":["Amgen Inc.","Amgen Inc. (NASDAQ:AMGN)","AMGN","Array Biopharma Inc","Array Biopharma Inc (NASDAQ:ARRAY)","NASDAQ","NASDAQ:AMGN","NASDAQ:ARRAY"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975","url":"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975","name":"Amgen, Inc. (NASDAQ:AMGN) And Array Biopharma Inc (NASDAQ:ARRY) Partners For Inflammation Discoveries - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/07\/39981-images__7_.jpeg","datePublished":"2017-07-26T11:17:17+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/07\/39981-images__7_.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/07\/39981-images__7_.jpeg","width":275,"height":183},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/amgen-inc-nasdaqamgn-and-array-biopharma-inc-nasdaqarry-partners-for-inflammation-discoveries-39975#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Amgen, Inc. (NASDAQ:AMGN) And Array Biopharma Inc (NASDAQ:ARRY) Partners For Inflammation Discoveries"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e82d48e74e653b113f0f9186826f808d","name":"Benjamin Roussey","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e051c9045b5c74768cca8f069d353d6ff45d41d241616ca1151ef20f3f86ff14?s=96&d=mm&r=g","caption":"Benjamin Roussey"},"description":"Benjamin Roussey is from Sacramento, California. He has two master\u2019s degrees and served four years in the U.S. Navy. His bachelor\u2019s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master\u2019s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing. http:\/\/www.facebook.com\/ben.rouss","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/benjamin-roussey"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/39975","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=39975"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/39975\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/39982"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=39975"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=39975"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=39975"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=39975"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}